Geo News
Community curated by people like you
LatestAICryptoHealthWorld AffairsUS Politics
GE HealthCare in talks to acquire Sofie Biosciences for $1 billion
00

GE HealthCare in talks to acquire Sofie Biosciences for $1 billion

Sep 13, 2026

GE HealthCare Technologies is in talks to acquire radiopharmaceutical developer Sofie Biosciences for approximately $1 billion. The deal, which could be announced as soon as mid-September 2026, aims to bolster GE HealthCare's diagnostics division. Since its January 2023 spin-off from General Electric, GE HealthCare's stock has risen just 12%, trailing sister spin-offs GE Vernova and GE Aerospace. The company is also conducting a strategic review of its patient care solutions division.

Sofie Biosciences acquisition talks

  • ▪The potential acquisition of Sofie Biosciences would mark the second major acquisition for GE HealthCare Technologies since its spin-off from General Electric
  • ▪GE HealthCare Technologies is in talks to acquire Sofie Biosciences, a private equity-backed radiopharmaceutical developer, for approximately $1 billion, according to reports on September 13, 2026
  • ▪Sofie Biosciences is largely owned by its founders, management, and private equity group Trilantic, which acquired a 25.8% stake in 2024 that valued the business at up to $550 million
  • ▪The potential acquisition of Sofie Biosciences by GE HealthCare Technologies could be announced as soon as the week of September 14, 2026, provided there are no last-minute snags

Radiopharmaceutical cancer diagnostics

  • ▪The acquisition of Sofie Biosciences is intended to bolster GE HealthCare Technologies' pharmaceutical diagnostics division, which supplies agents and chemicals used in medical scans
  • ▪Sofie Biosciences, based in Dulles, Virginia, specializes in radioactive chemicals and is developing radioisotopes for use in PET scans to detect gastro-oesophageal and pancreatic cancers

GE HealthCare post-split performance

  • ▪GE HealthCare Technologies spun off from General Electric in January 2023, followed by the spin-off of power company GE Vernova in April 2024
  • ▪As of September 13, 2026, GE HealthCare Technologies' shares have risen 12% since its opening trading day, giving it a market value of $28.8 billion
  • ▪Since the General Electric split, GE Vernova's market capitalization has increased sevenfold to $254 billion, while GE Aerospace's shares have more than doubled

Strategic business review

  • ▪GE HealthCare Technologies announced a comprehensive review of strategic options for its patient care solutions division in July 2026
  • ▪The July 2026 strategic review of the patient care solutions division is aimed at boosting performance by refocusing GE HealthCare Technologies on its core operations

Trian Fund stake increase

  • ▪Trian Fund Management played an instrumental role in the three-way corporate break-up of General Electric
  • ▪Billionaire investor Nelson Peltz's Trian Fund Management boosted its stake in GE HealthCare Technologies to nearly $200 million, as disclosed in a July 2026 regulatory filing

2 sources

Reuters
GE HealthCare in talks over possible $1 billion deal for Sofie Biosciences, FT reports | Reuters
View source article
Financial Times
GE HealthCare in talks over $1bn deal for maker of cancer scan chemicals
View source article

Featured stories

View more in Pharma

US and allies agree to jointly guard AI supply chains from China

Nov 15, 2026 · 4 sources

Story comments

Loading comments…

Topics

PharmaMedical imagingFinancial ties

Featured stories

View more in Pharma

US and allies agree to jointly guard AI supply chains from China

Nov 15, 2026 · 4 sources